Cancer research is in the forefront of biological research specialties. Cancer signaling pathways and phenotypic assays form the core of cancer biology research. Current research scenario is witnessing a resurgence of interest in phenotypic screens in drug discovery as an alternative to target-focused approaches. With oncology being one of the most active therapeutic specialties, phenotypic assays pertinent to this area are of tremendous worth.
With this advanced research interest in mind, Stellixir provides specialized and validated cancer signaling pathways and phenotypic assays.
|Phospo-ERK assay||c-Jun test|
|Ca2+ assay||HIF-1 alpha assay|
|cAMP assay||NF-kappa B/p65|
|Phospho-CREB assay||STAT 1,2,3 & 6 assay|
|Phospo-mTOR assay||EGFR assay|
|Akt assay||Cell cycle analysis|
|p38 activity assay||Clonogenicity assay|
|JNK activity assay||Cell migration assays|